- Mercia Technologies (MERC) confirms a new direct investment of £650,000 into Medherant Ltd.

Medherant is a novel transdermal patch drug delivery system company, and this investment brings another opportunity with high growth potential into Mercia's portfolio of direct investments.

Mercia's investment is part of a syndicated £1.5million fundraising round that would support taking the Company's patches through the Good Manufacturing Practice and pre-clinical work required to start clinical work and to enable the early commercialisation of its technology.

Story provided by